Kornitzer Capital Management Inc. KS Trims Holdings in Agilent Technologies, Inc. (NYSE:A)

Kornitzer Capital Management Inc. KS cut its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 22.1% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 47,696 shares of the medical research company's stock after selling 13,551 shares during the quarter. Kornitzer Capital Management Inc. KS's holdings in Agilent Technologies were worth $5,579,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Redwood Park Advisors LLC purchased a new stake in Agilent Technologies during the 4th quarter valued at about $27,000. Lee Danner & Bass Inc. purchased a new stake in Agilent Technologies during the 4th quarter valued at about $29,000. Whipplewood Advisors LLC grew its position in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company's stock valued at $29,000 after purchasing an additional 186 shares during the last quarter. Sunbelt Securities Inc. grew its position in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company's stock valued at $30,000 after purchasing an additional 192 shares during the last quarter. Finally, Opal Wealth Advisors LLC purchased a new stake in Agilent Technologies during the 1st quarter valued at about $31,000.

Agilent Technologies Stock Performance

A opened at $113.21 on Wednesday. The company has a current ratio of 2.09, a quick ratio of 1.60 and a debt-to-equity ratio of 0.55. The company has a market cap of $32.16 billion, a price-to-earnings ratio of 27.95, a PEG ratio of 3.64 and a beta of 1.23. The company's 50 day moving average is $115.63 and its 200 day moving average is $122.49. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.26 by $0.05. The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The firm's revenue was up 6.0% compared to the same quarter last year. During the same quarter last year, the firm posted $1.22 earnings per share. On average, equities research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies's payout ratio is 24.44%.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,508 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the transaction, the chief executive officer owned 37,448 shares of the company's stock, valued at $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. Leerink Partners increased their price objective on shares of Agilent Technologies to $135.00 and gave the company a "buy" rating in a research report on Friday, May 30th. TD Cowen lifted their price target on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research note on Thursday, May 29th. UBS Group reduced their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research note on Thursday, May 29th. Wells Fargo & Company reduced their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research note on Thursday, April 17th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating for the company in a research note on Thursday, May 29th. Six research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $139.77.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.